Ottawa, ON – ABcann Global Corporation (TSX-V:ABCN) (“ABcann” or the “Company”) announced that it has amended and extended the research contract currently in place between its Canadian operating subsidiary, ABcann Medicinals Inc., and the University of Guelph, of Guelph, Ontario.
The agreement, which dates back to Jan. 1, 2015, has been extended to Dec. 31, 2018, with the option to extend if mutually agreed upon. The research is focused on Controlled Environment Production of Medicinal Cannabis and is being conducted at the Controlled Environment Systems Research Facility (CESRF) under the direction of Dr. Michael Dixon at the University of Guelph. A portion of the research is also being conducted within ABcann’s research lab in Napanee which has been dedicated solely to the University of Guelph studies.
The multi-year research program is focused on a number of projects designed to enhance the ABcann process in terms of control,